Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Snap On Incorporated — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Snap On Incorporated trades at $360.27 (market cap $18.62B). The key difference: Snap On Incorporated is far larger — about 10.9× Nuvation Bio Inc. Class A Common Stock's market cap, and Snap On Incorporated pays a 2.71% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Snap On Incorporated for 36 Days on average.
| NUVB | SNA | |
|---|---|---|
Market Cap | $1.71B | $18.62B |
Volume | 5,448,712 | 360,121 |
Sector | Health | Industrials |
52-Week High | $9.54 | $419.31 |
52-Week Low | $3.41 | $327.33 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $1.30B | $18.25B |
Dividend Yield | — | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Snap-on Incorporated (SNA) trades at $359.89, down 2.37% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company maintains strong profitability with a 19.6% net income margin and a 17.58% ROE, though Q1 2026 earnings slightly missed expectations. Recent news highlights gross margin expansion and institutional position adjustments.
The outlook is supported by analyst consensus with a $449 price target and 66.7% buy ratings, but risks include valuation premiums and mixed segment trends. Earnings growth from innovation and RCI initiatives remains a key catalyst, though integration costs and softer OEM demand pose execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
